InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.430
+0.090 (6.72%)
At close: Dec 5, 2025, 4:00 PM EST
1.360
-0.070 (-4.90%)
After-hours: Dec 5, 2025, 7:57 PM EST
InMed Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 6 | 4 | 2 | 3 | 10 | 26 | |
| Market Cap Growth | 82.42% | 65.68% | -23.21% | -68.01% | -62.35% | -20.62% | |
| Enterprise Value | -3 | 0 | -4 | -6 | 5 | 16 | |
| Last Close Price | 1.43 | 3.25 | 5.31 | 18.53 | 235.20 | 1590.00 | |
| PS Ratio | 1.18 | 0.79 | 0.52 | 0.75 | 8.85 | - | |
| PB Ratio | 0.49 | 0.29 | 0.26 | 0.26 | 1.06 | 3.47 | |
| P/TBV Ratio | 0.56 | 0.33 | 0.32 | 0.30 | 1.38 | 4.05 | |
| EV/Sales Ratio | - | 0.01 | - | - | 4.24 | - | |
| Debt / Equity Ratio | 0.06 | 0.06 | 0.11 | 0.03 | 0.09 | 0.04 | |
| Asset Turnover | 0.40 | 0.36 | 0.36 | 0.31 | 0.10 | - | |
| Inventory Turnover | 3.02 | 2.94 | 2.44 | 1.33 | - | - | |
| Quick Ratio | 6.25 | 6.30 | 3.53 | 4.61 | 1.90 | 3.35 | |
| Current Ratio | 6.95 | 6.99 | 4.41 | 5.66 | 2.89 | 3.78 | |
| Return on Equity (ROE) | -82.17% | -72.10% | -72.08% | -75.09% | -226.07% | -153.95% | |
| Return on Assets (ROA) | -41.59% | -36.12% | -39.22% | -38.94% | -75.28% | -70.65% | |
| Return on Capital (ROIC) | -45.70% | -40.66% | -44.89% | -46.85% | -96.98% | -89.75% | |
| Return on Capital Employed (ROCE) | -67.10% | -57.60% | -82.60% | -69.20% | -143.60% | -131.40% | |
| Earnings Yield | -145.20% | -208.04% | -324.14% | -257.74% | -192.96% | -39.86% | |
| FCF Yield | -133.47% | -197.97% | -295.41% | -241.44% | -162.08% | -38.25% | |
| Buyback Yield / Dilution | -699.74% | -156.13% | -211.26% | -336.59% | -108.64% | -28.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.